Sort
326,823 grants matching “clinical trial”
SPORE in Breast Cancer
$2,218,149Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2019 · CA
Molecular Diagnostics Core Laboratory
$2,218,020Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Melanoma and Skin Cancer Program SPORE
$2,217,934Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
PumpKIN Preclinical Program
$2,217,933Allen Dipalma · University Of Pittsburgh At Pittsburgh · N01 · FY2010 · HL
SC COBRE for TranslationalResearch Improving MusculoskeletalHealth (SC-TRIMH)
$2,217,769Hai Yao · Clemson University · P20 · FY2025 · GM
LIPS-A: Lung Injury Prevention Study with Aspirin
$2,217,606Ognjen Gajic · Mayo Clinic Rochester · U01 · FY2013 · HL
CENTER FOR PSYCHO-ONCOLOGY RESEARCH
$2,217,094University Of Miami Coral Gables · P50 · FY2003 · CA
Developing and Evaluating In-Home Supportive Technology for Dementia Caregivers
$2,217,090Gene Wang · People Power Company · R44 · FY2020 · AG
PERIODONTAL INTERVENTION FOR CARDIAC EVENTS: PILOT TRIAL
$2,216,898State University Of New York At Buffalo · U01 · FY2001 · DE
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$2,216,874University Of Miami School Of Medicine · U10 · FY2001 · DA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,216,839Harry Bernard Greenberg · Stanford University · UL1 · FY2009 · RR
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
$2,216,758Michael J Boeckh · Fred Hutchinson Cancer Center · UH3 · FY2022 · HL
Alzheimer's Prevention Initiative ADAD Colombia Trial
$2,216,620Eric M Reiman · Banner Health · R01 · FY2020 · AG
Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation
$2,216,525Peter Scott Heeger · Cedars-Sinai Medical Center · R01 · FY2025 · AI
Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation
$2,216,525Peter Scott Heeger · Cedars-Sinai Medical Center · R01 · FY2024 · AI
Neuroblastoma Biology and Therapy
$2,216,467Garrett M Brodeur · Children'S Hosp Of Philadelphia · P01 · FY2007 · CA
Targeted antigen receptor treatment of cancer
$2,216,397David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Center for Molecular Epidemiology
$2,216,337Margaret Rita Karagas · Dartmouth College · P20 · FY2017 · GM
Colon Cancer Family Registry Cohort
$2,216,188Robert William Haile · Stanford University · UM1 · FY2014 · CA
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
$2,216,013Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2021 · DA
Integrative Pathophysiology of Solid Tumors
$2,216,012Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2008 · CA
DTMI-Center for Thrombotic and Hemostatic Disorders
$2,215,887Bruce Alan Sullenger · Duke University · U54 · FY2016 · HL
A Reinforcement Approach to Improve Diabetes Management
$2,215,737Nancy M Petry · University Of Connecticut Sch Of Med/Dnt · DP3 · FY2012 · DK
Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases
$2,215,657Katherine Teresa Mills · Tulane University Of Louisiana · P20 · FY2025 · GM
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
$2,215,284Samson T Jacob · Ohio State University · P01 · FY2007 · CA